Daxas® Tablets for COPD

Daxas® is a prescription tablet containing roflumilast for COPD flare-up prevention. This guide explains how it works, who it may suit, and how you can access it with US delivery from Canada. You can also review ways to plan for Daxas 500 mcg without insurance.

What Daxas Is and How It Works

Daxas® contains roflumilast, a phosphodiesterase-4 (PDE4) inhibitor. It helps reduce inflammation in the airways of adults with COPD, particularly those with chronic bronchitis and prior exacerbations. The treatment is not a bronchodilator and does not give quick relief for sudden breathing symptoms. For urgent symptoms, keep your rescue inhaler available as directed by your prescriber. Learn more about the condition in our Chronic Obstructive Pulmonary Disease Copd hub.

Border Free Health connects U.S. patients with licensed Canadian partner pharmacies; prescriptions are verified with prescribers before dispensing.

Labeling for this medicine follows approved references, including Daxas AstraZeneca sources and official regulators. Some people search for Daxas Canadian pricing while comparing options, but your prescriber’s guidance should drive all treatment choices.

Who It’s For

This medicine is indicated to reduce the risk of COPD exacerbations in adults with severe COPD associated with chronic bronchitis and a history of flare-ups. It is used as an add-on to your maintenance inhalers when appropriate. The therapy is not for treating asthma or for sudden shortness of breath. Your healthcare professional may reassess therapy if weight loss, mood changes, or other concerns arise.

Avoid use if you have moderate to severe liver impairment. Tell your prescriber about a history of depression, suicidal thoughts, or significant unintentional weight loss. Report any new or worsening mood symptoms promptly. Some prescribers consider roflumilast tablets from Canada as an option within broader COPD plans, always based on individual risk and benefit.

Dosage and Usage

The standard schedule is one tablet taken once daily, with or without food. Swallow tablets whole with water. If stomach upset occurs, taking it with food may help. Do not crush or split tablets unless advised by your prescriber. This medicine is for long-term control; it does not replace your rescue inhaler.

Try to take your dose at the same time each day. Consistency helps you build a routine and reduces missed doses. For inhaler technique and adherence tips that often support COPD care, see Mastering Combivent Respimat. Never start, stop, or change your regimen without your prescriber’s advice. If you notice new symptoms or unexpected effects, contact a clinician.

Strengths and Forms

The product is available as roflumilast 500 mcg tablets in blistered packs in many markets. Availability and pack sizes can vary by supplier and country.

Missed Dose and Timing

If you miss a dose, take it when you remember on the same day. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at once. Building a routine, setting phone reminders, or using a pill organizer can help reduce missed doses.

Storage and Travel Basics

Store tablets at typical room temperature in a dry place, away from moisture. Keep them in the original packaging to protect from humidity and to preserve lot and label information. Always store out of reach of children and pets. When traveling, carry your medicine in hand luggage with a copy of your prescription and a list of your medicines. Keep it in the labeled container for security checks and to avoid mix-ups. For country-of-origin details, you can explore Canada sourcing pages on our site.

Benefits

This anti-inflammatory therapy can help reduce the frequency of COPD exacerbations when used with appropriate maintenance inhalers. It offers once-daily oral dosing, which some people find simpler than adding another inhaler. The medicine is not a steroid and does not deliver immediate airway opening. Many patients still require bronchodilators or inhaled corticosteroids as part of a complete plan guided by their clinician.

• Fewer exacerbations: may lower flare-up risk in selected adults
• Oral option: a tablet rather than an additional inhaler
• Daily routine: once-daily schedule supports consistent use
• Complementary role: used alongside COPD maintenance inhalers

Side Effects and Safety

Common side effects can include diarrhea, nausea, stomach discomfort, decreased appetite, weight loss, headache, insomnia, and dizziness. Many effects are mild to moderate and may lessen over time. If you experience persistent or bothersome symptoms, contact your prescriber.

Serious risks are uncommon but can include mood changes, depression, or suicidal thinking. Seek urgent help for any severe mood symptoms. Significant weight loss can occur; your healthcare professional may monitor weight and overall health. Avoid use if you have moderate to severe liver impairment. Hypersensitivity reactions are possible; stop the medicine and get care for signs of allergic reaction such as rash, swelling, or trouble breathing.

Drug Interactions and Cautions

Tell your healthcare professional about all medicines and supplements you use. Strong enzyme inducers, such as rifampin, carbamazepine, and phenytoin, may reduce roflumilast levels and effectiveness. Certain inhibitors, including some macrolide antibiotics or fluvoxamine, can increase exposure and side effects. Discuss potential interactions with theophylline and other COPD therapies. Alcohol may worsen side effects in some people.

Use caution if you have a history of depression or suicidal thoughts. Report mood changes promptly. If you notice unintended weight loss, contact your prescriber for guidance. Refer to the official label for full interaction details and warnings.

What to Expect Over Time

This preventive therapy works gradually as part of a long-term COPD plan. You should not expect immediate symptom relief after a single dose. When used consistently with maintenance therapies, the goal is fewer exacerbations over time and more stable day-to-day control. Your clinician may monitor your weight, mood, and flare-up history. Keep a simple symptom or rescue-inhaler-use diary to discuss during follow-ups.

If side effects occur early, they may ease with continued use. If they persist or concern you, consult your prescriber about options. Never discontinue abruptly without professional advice. For broader COPD education, you can read What Is Spiriva and our awareness features like World Lung Day and Respiratory Care Week.

Compare With Alternatives

Roflumilast is not a bronchodilator and is often used in addition to inhaled maintenance therapies. Alternatives in a COPD regimen may include a LAMA, an ICS/LABA, or a LAMA/LABA inhaler. Two options we carry include the LAMA/LABA combination Anoro Ellipta Inhaler and the LAMA maintenance option Spiriva Handihaler Refills. Your clinician will help decide which class fits your history and goals.

Pricing and Access

We highlight Canadian sourcing with US shipping from Canada to help you compare options. To review today’s Daxas price, use the product page to see availability and start checkout. Many patients compare cash-pay options when insurance limits coverage. Savings can vary by supply and manufacturer changes. Our Promotions page explains current offers when available. Checkout uses encrypted processes to help protect your information.

Availability and Substitutions

Supply can vary by manufacturer and distributor. If stock is limited, a prescriber may recommend a different COPD option with similar goals. If you are budget sensitive, you can discuss Daxas cash price considerations and whether a different class might meet your needs.

Patient Suitability and Cost-Saving Tips

Good candidates often include adults with severe COPD related to chronic bronchitis who have had exacerbations despite maintenance inhalers. People with moderate to severe liver problems should not use this medicine. Those with a history of depression, suicidal thoughts, or significant unintentional weight loss need careful monitoring. This therapy is not for acute symptom relief and does not replace bronchodilators.

• Discuss goals: clarify target outcomes and monitoring plans
• Build routine: set daily reminders for dosing
• Multi-month fills: fewer refills can lower per-fill effort
• Compare options: ask about roflumilast tablets from Canada and other classes
• Schedule follow-ups: review weight, mood, and rescue use
• Refill alerts: use calendar or app reminders

Questions to Ask Your Clinician

• Is this PDE4 inhibitor appropriate for my COPD history?
• How will we track exacerbations and adjust therapy?
• Which inhalers should I continue alongside this tablet?
• What signs suggest I should call you about side effects?
• Could any of my current medicines interact with roflumilast?
• What strategies can help manage early stomach side effects?
• How often should we review weight and mood changes?

Authoritative Sources

FDA DailyMed: Roflumilast (Daliresp) Prescribing InformationHealth Canada Drug Product DatabaseEMA EPAR: Daxas (Roflumilast)

Ready to get started? Order now with prompt, express shipping. Ships from Canada to US. This page is informational and does not replace your clinician’s advice. Always read the official label and follow your prescriber’s instructions.